M. Vadiaka

发表

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy

N. Tsavaris, C. Kosmas, M. Vadiaka, 2002, BMC Cancer.

Raltitrexed (Tomudex) Administration in Patients Failing Multiple Prior Chemotherapy Regimens in Advanced Colorectal Cancer: a Pilot Study

A. Angelopoulou, N. Tsavaris, C. Kosmas, 2002, Investigational New Drugs.

Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.

K. Letsas, K. Vlachos, A. Sideris, 2015, Journal of electrocardiology.

Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes.

N. Tsavaris, C. Kosmas, H. Skopelitis, 2008, European journal of cancer care.

5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.

H. Kasparian, N. Tsavaris, C. Kosmas, 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

A simplified premedication schedule for 1-hour paclitaxel administration.

N. Tsavaris, C. Kosmas, M. Vadiaka, 2005, The journal of supportive oncology.

Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction

N. Tsavaris, C. Kosmas, J. Boletis, 2001, Medical oncology.

Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.

N. Tsavaris, C. Kosmas, M. Efremidis, 2002, Medical science monitor : international medical journal of experimental and clinical research.

Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.

K. Syrigos, G. Kouraklis, H. Gogas, 2003, Anticancer research.

Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y

N. Tsavaris, C. Kosmas, Konstantinos Papoutsis, 2000, Chemotherapy.

Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases.

G. Vaiopoulos, N. Tsavaris, C. Kosmas, 2006, Oncology reports.

Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.

P. Kosmidis, N. Tsavaris, C. Kosmas, 2000, Anticancer research.

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

N. Tsavaris, C. Kosmas, C Kosmas, 2002, British Journal of Cancer.

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.

N. Malamos, N. Tsavaris, C. Kosmas, 2001, European journal of cancer.

A phase I‐II study of docetaxel‐ifosfamide‐cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer

D. Dimitropoulos, N. Tsavaris, C. Kosmas, 2002, International journal of cancer.

Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study

E. Papalambros, C. Kosmas, A. Polyzos, 2003, Cancer Chemotherapy and Pharmacology.

Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination

E. Papalambros, N. Tsavaris, C. Kosmas, 2002, Chemotherapy.

Etoposide, Leucovorin (LV) and 5-Fluorouracil (5-FU) in 5-FU+LV Pre-Treated Patients with Advanced Colorectal Cancer

G. Kouraklis, N. Tsavaris, C. Kosmas, 2002, Journal of chemotherapy.

Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.

P. Kosmidis, D. Skarlos, N. Tsavaris, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation.

G. Filippatos, K. Letsas, C. Mihas, 2009, The Canadian journal of cardiology.

Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.

N. Malamos, N. Tsavaris, C. Kosmas, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A case of systemic karyomegaly associated with interstitial nephritis.

M. Vadiaka, C. Koufos, F. Sotsiou, 1998, Annales de medecine interne.

Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review

N. Vallianou, D. Kounatidis, F. Panagopoulos, 2020, Rheumatology International.

Coexistence of Hodgkin and Non-Hodgkin lymphoma; Composite Lymphoma (CL) in a patient presenting with waxing and waning lymphadenopathy.

D. Rontogianni, E. Geladari, G. Kafetzis, 2019, Cardiovascular & hematological disorders drug targets.

Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

S. Giannouli, G. Pangalis, M. Siakantaris, 2002, Anticancer research.

Adenocarcinoma of the Colon Presenting as Polymyositis: Case Report

G. Vaiopoulos, N. Tsavaris, C. Kosmas, 2002, Journal of chemotherapy.

Gemcitabine and docetaxel as second‐line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum‐based regimens

N. Malamos, N. Tsavaris, C. Kosmas, 2001, Cancer.

A Phase II study of paclitaxel‐ifosfamide‐cisplatin combination in advanced nonsmall cell lung carcinoma

T. Dosios, N. Malamos, N. Tsavaris, 2000, Cancer.

Leucovorin + 5-Fluorouracil plus Dipyridamole in Leucovorin + 5-Fluorouracil-Pretreated Patients with Advanced Colorectal Cancer: A Pilot Study of Three Different Dipyridamole Regimens

N. Tsavaris, C. Kosmas, A. Polyzos, 2001, Tumori.

Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: Ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate

P. Ziakas, N. Sipsas, C. Kosmas, 2007, Scandinavian journal of infectious diseases.

Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.

N. Tsavaris, C. Kosmas, A. Zerai, 2001, Journal of experimental & clinical cancer research : CR.

Comparative Study of Tropisetron with the Addition of Dexamethasone or Alprazolam in Breast Cancer Patients Receiving Adjuvant Chemotherapy with CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil)

N. Tsavaris, C. Kosmas, S. Sougioultzis, 2001, Journal of chemotherapy.